Who Owns Medline Industries Company?

Medline Industries Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Controls Medline Industries?

Understanding the ownership structure of a healthcare giant like Medline Industries is crucial for anyone interested in the industry's future. The company's strategic direction, financial performance, and market position are all significantly influenced by its ownership. This exploration will shed light on the key players behind this major medical supplier.

Medline Industries, a privately held healthcare company, has a fascinating history, evolving from a small garment factory to a global leader. Its Medline Industries SWOT Analysis can help you understand the company's strengths and weaknesses. The company's journey, from its founding in 1966 to its current status, reveals a story of growth and strategic shifts, particularly concerning its ownership.

The story of Medline Industries begins with the Mills family. Founded in 1966 by brothers Jim and Jon Mills, the company has a rich history rooted in the medical supply industry.

Their entrepreneurial journey started with a modest warehouse space in Evanston, Illinois. This marked the beginning of what would become a significant player in the healthcare sector.

The founders, Jim and Jon Mills, were the grandsons of A.L. Mills, who had started Mills Hospital Supplies Inc. in 1912. This family legacy set the stage for Medline's future.

Early Roots

A.L. Mills' initial venture, Mills Hospital Supplies Inc., focused on manufacturing surgical gowns and uniforms. This laid the groundwork for the family's continued involvement in the medical supply business.

Transition

In the 1920s, Irving Mills, A.L.'s son, took over the business. He expanded the scope to include the distribution of general medical supplies, broadening the company's reach.

Sale and Rebirth

Irving Mills sold the company to Cenco in 1961. Jim and Jon Mills later left Cenco to establish Medline, marking a new chapter in the family's business endeavors.

Public to Private

Medline briefly went public in 1972. However, the Mills family took the company private again in 1977. This decision underscored their commitment to long-term control and vision.

Family Control

The Mills family's decision to maintain private ownership has been a defining characteristic of Medline's identity. This has allowed them to focus on the company's strategic direction.

Initial Footprint

Medline began with approximately 12,000 square feet of warehouse space. This modest beginning has grown into a massive global operation.

Key Aspects of Medline's Early Ownership

The early years of Medline were marked by significant decisions and a clear vision. The Mills family's control has been a key factor in the company's growth and strategy. Understanding the target market of Medline Industries can provide further insights into its success.

• Medline Industries was founded in 1966 by Jim and Jon Mills.
• The company started with a warehouse in Evanston, Illinois.
• Medline briefly became a public company in 1972.
• The Mills family took Medline private again in 1977.

Medline Industries SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership structure of Medline Industries underwent a major shift in June 2021. A consortium of private equity firms, including Blackstone, Carlyle, and Hellman & Friedman, acquired a majority stake. This leveraged buyout valued the company at $34 billion, with the private equity groups contributing roughly $17 billion in equity. Singapore's sovereign wealth fund, GIC, also participated in this investment.

Despite the majority acquisition by private equity, the Mills family, the founders, maintained significant ownership, holding just over 25%. This arrangement allowed Medline to remain a privately held, family-led company. The strategic partnership aimed to fuel expansion, accelerate international growth, and strengthen its global supply chain. Before this, Medline was primarily family-owned, with a brief period as a public company in the 1970s. This move introduced substantial capital for growth initiatives. In 2020, prior to the acquisition, Medline had annual sales of $17.5 billion. By 2022, sales reached $21.2 billion, and by 2024, annual sales exceeded $25.5 billion.

The Medline company has seen substantial changes in its ownership. The 2021 acquisition by private equity firms brought in significant capital, while the Mills family's continued ownership ensured a degree of continuity in leadership and strategy. This shift has supported Medline's expansion and financial growth, as shown by the increase in annual sales. For more details, you can read this article about Medline Industries.

Key Takeaways on Medline Ownership

The ownership of Medline Industries is primarily held by private equity firms and the founding Mills family.

• Private equity firms hold a majority stake.
• The Mills family remains a significant shareholder.
• This structure supports growth and expansion.
• Annual sales exceeded $25.5 billion in 2024.

Medline Industries PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Following the 2021 acquisition, the Mills family, the original founders, retained significant influence over the Medline Industries. They continued to be the largest single shareholder, ensuring their strategic vision remained central to the company's direction. The board of directors includes members of the Mills family, who hold key leadership positions.

Charlie Mills served as Chairman of the Board, with Andy Mills and Jim Abrams as Vice Chairmen, reflecting the family's continued involvement in governance. This structure enabled a balance between the external investment from private equity firms and the legacy of the founding family, ensuring continuity in the company's strategic direction. The leadership transition in 2023 saw Jim Boyle become CEO, demonstrating a planned succession while maintaining family influence within the company.

The ongoing leadership transition, with Jim Pigott's planned retirement at the end of 2025 and the promotions of Amanda Laabs and Steve Miller, shows a proactive approach to succession planning. This ensures that Medline Industries is prepared for future challenges while maintaining its core values. The details about the Medline ownership and the structure of the leadership team show a blend of family legacy and external expertise. For more insights, you can explore the Brief History of Medline Industries.

Key Leadership and Governance

The Mills family maintains significant influence, ensuring strategic continuity. Jim Boyle was recognized among the 100 Most Influential People in Healthcare for 2024.

• Charlie Mills as Chairman of the Board.
• Jim Boyle as CEO since October 1, 2023.
• Planned succession with Amanda Laabs and Steve Miller in 2025.
• Balance of family legacy and external investment.

Medline Industries Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

The ownership of Medline Industries has seen significant shifts in recent years. In June 2021, a consortium of private equity firms, including Blackstone, Carlyle, and Hellman & Friedman, acquired a majority stake in the company. This $34 billion leveraged buyout allowed the Mills family to remain the largest single shareholder while injecting substantial capital for future expansion. GIC also invested in the deal.

The company is preparing for a potential US initial public offering (IPO) as early as the second quarter of 2025, aiming to raise over $5 billion. This move could value the company at approximately $50 billion. Medline confidentially filed for this potential IPO in December 2024, after being private since 1977. This IPO represents a significant strategic shift and an exit opportunity for the private equity firms involved.

In terms of leadership, Jim Pigott is scheduled to retire as President and COO at the end of 2025. Amanda Laabs is being promoted to Chief Product Officer and Steve Miller to Chief Operating Officer, both effective January 1, 2025. The company's focus continues on expanding its distribution centers to strengthen its global supply chain.

Ownership Structure

Medline's ownership is primarily held by private equity firms and the Mills family. The 2021 leveraged buyout brought in Blackstone, Carlyle, and Hellman & Friedman as major stakeholders. The Mills family remains the largest single shareholder.

Future Plans

The company is planning an IPO in 2025, which would mark a significant change in its ownership structure. This IPO is expected to raise billions and could value the company at around $50 billion. The IPO would provide an exit strategy for the private equity investors.

Leadership Transition

Medline is undergoing a leadership transition with key appointments. Jim Pigott will retire at the end of 2025. Amanda Laabs and Steve Miller will take on new roles as Chief Product Officer and Chief Operating Officer, respectively, starting January 1, 2025.

Financial Performance

Medline's revenue has shown consistent growth. Annual sales exceeded $23 billion in 2023 and surpassed $25.5 billion in 2024. The company continues to invest in its infrastructure, including expanding its distribution centers.

Medline Industries Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs